Fibrotic Inflammatory Rheumatic Diseases (Nor-FIORD) Publications
-
Risk prediction modelling in idiopathic inflammatory myositis-associated interstitial lung disease based on seven factors including serum KL-6 and lung ultrasound B-lines
Clin Exp Rheumatol (in press)
DOI 10.55563/clinexprheumatol/ylf0oe, PubMed 39360376 -
A versatile role for lung ultrasound in systemic autoimmune rheumatic diseases related pulmonary involvement: a narrative review
Arthritis Res Ther, 26 (1), 164
DOI 10.1186/s13075-024-03399-2, PubMed 39294670 -
Development of a multivariable prediction model for progression of systemic sclerosis-associated interstitial lung disease
RMD Open, 10 (3)
DOI 10.1136/rmdopen-2024-004240, PubMed 39242112 -
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus
Autoimmun Rev, 23 (7-8), 103581
DOI 10.1016/j.autrev.2024.103581, PubMed 39069240 -
Design of ANCHOR-RA: a multi-national cross-sectional study on screening for interstitial lung disease in patients with rheumatoid arthritis
BMC Rheumatol, 8 (1), 19
DOI 10.1186/s41927-024-00389-4, PubMed 38773593 -
Arthritis in patients with very early systemic sclerosis: a comprehensive clinical and prognostic analysis
Rheumatology (Oxford) (in press)
DOI 10.1093/rheumatology/keae247, PubMed 38724227 -
Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research (EUSTAR) cohort and a systematic literature review
Eur J Intern Med, 125, 104-110
DOI 10.1016/j.ejim.2024.03.035, PubMed 38599922 -
Therapeutic management of fibrosis in systemic sclerosis patients - an analysis from the Swiss EUSTAR cohort
Swiss Med Wkly, 154, 3630
DOI 10.57187/s.3630, PubMed 38579324 -
Adaptive multi-interventional trial platform to improve patient care for fibrotic interstitial lung diseases
Thorax, 79 (8), 788-795
DOI 10.1136/thorax-2023-221148, PubMed 38448221 -
The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis-Interstitial Lung Disease in the European Scleroderma Trial and Research Database
Diagnostics (Basel), 14 (3)
DOI 10.3390/diagnostics14030295, PubMed 38337811 -
A validation of register-derived diagnoses of interstitial lung disease in patients with inflammatory arthritis: data from the NOR-DMARD study
Scand J Rheumatol, 53 (3), 173-179
DOI 10.1080/03009742.2024.2306716, PubMed 38314728 -
Histogram-Based Densitometry Index to Assess the Severity of Interstitial Lung Disease in Systemic Sclerosis in Standard and Low-Dose Computed Tomography
J Rheumatol, 51 (3), 270-276
DOI 10.3899/jrheum.2023-0415, PubMed 38302169 -
Call for papers: Sex and gender in rheumatology
Lancet Rheumatol, 4 (3), e168
DOI 10.1016/S2665-9913(22)00036-4, PubMed 38288935 -
Circulating collagen neo-epitopes and their role in the prediction of fibrosis in patients with systemic sclerosis: a multicentre cohort study
Lancet Rheumatol, 3 (3), e175-e184
DOI 10.1016/S2665-9913(20)30385-4, PubMed 38279380 -
European consensus statements for interstitial lung disease in systemic sclerosis - Authors' reply
Lancet Rheumatol, 2 (6), e319-e320
DOI 10.1016/S2665-9913(20)30098-9, PubMed 38273593 -
Safety and tolerability of nintedanib in patients with interstitial lung diseases in subgroups by sex: a post-hoc analysis of pooled data from four randomised controlled trials
Lancet Rheumatol, 4 (10), e679-e687
DOI 10.1016/S2665-9913(22)00215-6, PubMed 38265966 -
Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort
Lancet Rheumatol, 4 (11), e785-e794
DOI 10.1016/S2665-9913(22)00217-X, PubMed 38265945 -
The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements
Lancet Rheumatol, 2 (2), e71-e83
DOI 10.1016/S2665-9913(19)30144-4, PubMed 38263663 -
Preclinical or subclinical rheumatoid arthritis-associated interstitial lung disease: misleading terms with potentially deleterious consequences
Lancet Rheumatol, 5 (3), e116-e118
DOI 10.1016/S2665-9913(23)00033-4, PubMed 38251607 -
Characteristics and disease course of untreated patients with interstitial lung disease associated with systemic sclerosis in a real-life two-centre cohort
RMD Open, 10 (1)
DOI 10.1136/rmdopen-2023-003658, PubMed 38199606 -
Sex-specific difference in cardiac function in patients with systemic sclerosis: association with cardiovascular outcomes
RMD Open, 9 (4)
DOI 10.1136/rmdopen-2023-003380, PubMed 37949614 -
Phenotyping by persistent inflammation in systemic sclerosis associated interstitial lung disease: a EUSTAR database analysis
Thorax, 78 (12), 1188-1196
DOI 10.1136/thorax-2023-220541, PubMed 37798114 -
Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD)
BMJ Open Respir Res, 10 (1)
DOI 10.1136/bmjresp-2022-001580, PubMed 37709661 -
The phenotype of mixed connective tissue disease patients having associated interstitial lung disease
Semin Arthritis Rheum, 63, 152258
DOI 10.1016/j.semarthrit.2023.152258, PubMed 37696231 -
Differential sensitivity of the 2020 revised comprehensive diagnostic criteria and the 2019 ACR/EULAR classification criteria across IgG4-related disease phenotypes: results from a Norwegian cohort
Arthritis Res Ther, 25 (1), 163
DOI 10.1186/s13075-023-03155-y, PubMed 37670401 -
Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?
Arthritis Care Res (Hoboken), 76 (1), 88-97
DOI 10.1002/acr.25226, PubMed 37667424 -
Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database
JAMA Dermatol, 159 (8), 837-847
DOI 10.1001/jamadermatol.2023.1729, PubMed 37378994 -
Rheumatology congresses post COVID-19: we cannot regress
Lancet Rheumatol, 5 (7), e370-e371
DOI 10.1016/S2665-9913(23)00153-4, PubMed 37360002 -
Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung disease
Rheumatology (Oxford), 63 (3), 639-647
DOI 10.1093/rheumatology/kead280, PubMed 37294870 -
Clinical trial simulations in pulmonary fibrosis: patient-focused insights and adaptations
ERJ Open Res, 9 (3)
DOI 10.1183/23120541.00602-2022, PubMed 37260456 -
Scleroderma Skin: How Is Treatment Best Guided by Data and Implemented in Clinical Practice?
Rheum Dis Clin North Am, 49 (2), 249-262
DOI 10.1016/j.rdc.2023.01.003, PubMed 37028833 -
Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression
RMD Open, 9 (1)
DOI 10.1136/rmdopen-2022-002859, PubMed 36796874 -
The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort
Autoimmun Rev, 22 (4), 103290
DOI 10.1016/j.autrev.2023.103290, PubMed 36746368 -
Study protocol of an international patient-led registry in patients with pulmonary fibrosis using online home monitoring: I-FILE
BMC Pulm Med, 23 (1), 51
DOI 10.1186/s12890-023-02336-4, PubMed 36732734 -
Longitudinal Characterisation of the Gastrointestinal Tract Microbiome in Systemic Sclerosis
Eur Med J (Chelmsf), 7, 110-118
DOI 10.33590/emj/20-00043, PubMed 36711108 -
Effects of faecal microbiota transplantation on the small intestinal mucosa in systemic sclerosis
Rheumatology (Oxford), 62 (8), 2918-2929
DOI 10.1093/rheumatology/kead014, PubMed 36688692 -
Serum B-cell activating factor and lung ultrasound B-lines in connective tissue disease related interstitial lung disease
Front Med (Lausanne), 9, 1066111
DOI 10.3389/fmed.2022.1066111, PubMed 36590969 -
Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: a EUSTAR database analysis
Rheumatology (Oxford), 62 (7), 2483-2491
DOI 10.1093/rheumatology/keac660, PubMed 36413079 -
Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort
RMD Open, 8 (2)
DOI 10.1136/rmdopen-2022-002477, PubMed 36328401 -
Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research
Chest, 163 (3), 586-598
DOI 10.1016/j.chest.2022.09.044, PubMed 36244404 -
Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region
Rheumatology (Oxford), 62 (6), 2178-2188
DOI 10.1093/rheumatology/keac576, PubMed 36222557 -
Target organ expression and biomarker characterization of chemokine CCL21 in systemic sclerosis associated pulmonary arterial hypertension
Front Immunol, 13, 991743
DOI 10.3389/fimmu.2022.991743, PubMed 36211384 -
Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease
Rheumatology (Oxford), 62 (5), 1877-1886
DOI 10.1093/rheumatology/keac557, PubMed 36173318 -
Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database
Rheumatology (Oxford), 62 (4), 1559-1567
DOI 10.1093/rheumatology/keac533, PubMed 36099040 -
Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model
Rheumatology (Oxford), 62 (SI), SI91-SI100
DOI 10.1093/rheumatology/keac405, PubMed 35904554 -
Systemic sclerosis in the time of COVID-19
Lancet Rheumatol, 4 (8), e566-e575
DOI 10.1016/S2665-9913(22)00130-8, PubMed 35891634 -
Recent advances in the management of systemic sclerosis-associated interstitial lung disease
Curr Opin Pulm Med, 28 (5), 441-447
DOI 10.1097/MCP.0000000000000901, PubMed 35855572 -
High-resolution computed tomography of the chest for the screening, re-screening and follow-up of systemic sclerosis-associated interstitial lung disease: a EUSTAR-SCTC survey
Clin Exp Rheumatol, 40 (10), 1951-1955
DOI 10.55563/clinexprheumatol/7ry6zz, PubMed 35819810 -
Late skin fibrosis in systemic sclerosis: a study from the EUSTAR cohort
Rheumatology (Oxford), 62 (SI), SI54-SI63
DOI 10.1093/rheumatology/keac363, PubMed 35731139 -
Impact of lung function and baseline clinical characteristics on patient-reported outcome measures in systemic sclerosis-associated interstitial lung disease
Rheumatology (Oxford), 62 (SI), SI43-SI53
DOI 10.1093/rheumatology/keac325, PubMed 35640959 -
Anti-Endothelial Cell Antibodies are not frequently elevated in hospitalized patients with COVID-19
Acta Biomed, 93 (2), e2022043
DOI 10.23750/abm.v93i2.11196, PubMed 35546028 -
Selexipag treatment in patients with systemic sclerosis-associated pulmonary arterial hypertension in clinical practice, a case series
J Scleroderma Relat Disord, 5 (3), NP7-NP11
DOI 10.1177/2397198320916082, PubMed 35382522 -
Gastrointestinal involvement in systemic sclerosis: Effects on morbidity and mortality and new therapeutic approaches
J Scleroderma Relat Disord, 6 (1), 37-43
DOI 10.1177/2397198319891282, PubMed 35382247 -
Circulating biomarkers of systemic sclerosis - interstitial lung disease
J Scleroderma Relat Disord, 5 (2 Suppl), 41-47
DOI 10.1177/2397198319894851, PubMed 35382223 -
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort
Rheumatology (Oxford), 61 (12), 4786-4796
DOI 10.1093/rheumatology/keac188, PubMed 35348643 -
Anti-Endothelial Cell Antibodies are not frequently elevated in hospitalized patients with COVID-19
Acta Biomed, 93 (1), e2022026
DOI 10.23750/abm.v93i1.10799, PubMed 35315426 -
Tocilizumab in addition to standard of care in the management of COVID-19: a meta-analysis of RCTs
Acta Biomed, 93 (1), e2022014
DOI 10.23750/abm.v93i1.12208, PubMed 35315395 -
Serum markers of cardiac complications in a systemic sclerosis cohort
Sci Rep, 12 (1), 4661
DOI 10.1038/s41598-022-08815-8, PubMed 35304587 -
Gastrointestinal symptom severity and progression in systemic sclerosis
Rheumatology (Oxford), 61 (10), 4024-4034
DOI 10.1093/rheumatology/keac118, PubMed 35238377 -
Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experiment
Rheumatology (Oxford), 61 (10), 4035-4046
DOI 10.1093/rheumatology/keac126, PubMed 35238334 -
Nintedanib in Patients With Autoimmune Disease-Related Progressive Fibrosing Interstitial Lung Diseases: Subgroup Analysis of the INBUILD Trial
Arthritis Rheumatol, 74 (6), 1039-1047
DOI 10.1002/art.42075, PubMed 35199968 -
Dyspnoea and cough in patients with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial
Rheumatology (Oxford), 61 (11), 4397-4408
DOI 10.1093/rheumatology/keac091, PubMed 35150246 -
Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries
ERJ Open Res, 8 (1)
DOI 10.1183/23120541.00597-2021, PubMed 35083316 -
Computed tomography-based radiomics decodes prognostic and molecular differences in interstitial lung disease related to systemic sclerosis
Eur Respir J, 59 (5)
DOI 10.1183/13993003.04503-2020, PubMed 34649979 -
[Treatment of lung fibrosis in systemic rheumatic diseases (new treatment)]
Z Rheumatol, 80 (8), 743-754
DOI 10.1007/s00393-021-01067-3, PubMed 34505934 -
Interstitial lung diseases: quo vadis?
Lancet Respir Med, 9 (10), 1084-1087
DOI 10.1016/S2213-2600(21)00403-3, PubMed 34499873 -
Natural history and screening of interstitial lung disease in systemic autoimmune rheumatic disorders
Ther Adv Musculoskelet Dis, 13, 1759720X211037519
DOI 10.1177/1759720X211037519, PubMed 34471427 -
One-step closer to solve the mystery of predicting disease progression in systemic sclerosis associated interstitial lung disease?
Thorax, 76 (12), 1170-1171
DOI 10.1136/thoraxjnl-2021-217811, PubMed 34446525 -
The role of lung ultrasound B-lines and serum KL-6 in the screening and follow-up of rheumatoid arthritis patients for an identification of interstitial lung disease: review of the literature, proposal for a preliminary algorithm, and clinical application to cases
Arthritis Res Ther, 23 (1), 212
DOI 10.1186/s13075-021-02586-9, PubMed 34391465 -
Outcomes of extracorporeal life support for respiratory failure in children with primary immunodeficiencies
Perfusion, 38 (1), 37-43
DOI 10.1177/02676591211033946, PubMed 34278883 -
The attitudes and practices of physicians caring for patients with rheumatoid arthritis-associated interstitial lung disease: an international survey
Rheumatology (Oxford), 61 (4), 1459-1467
DOI 10.1093/rheumatology/keab552, PubMed 34260687 -
Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: study protocol for the randomised controlled phase II ReSScue trial
BMJ Open, 11 (6), e048541
DOI 10.1136/bmjopen-2020-048541, PubMed 34168032 -
Anticentromere Antibody Levels and Isotypes and the Development of Systemic Sclerosis
Arthritis Rheumatol, 73 (12), 2338-2347
DOI 10.1002/art.41814, PubMed 34042326 -
Representativeness of systemic sclerosis patients in interventional randomized trials: an analysis of the EUSTAR database
Rheumatology (Oxford), 61 (2), 743-755
DOI 10.1093/rheumatology/keab437, PubMed 33989387 -
Complement levels at admission as a reflection of coronavirus disease 2019 (COVID-19) severity state
J Med Virol, 93 (9), 5515-5522
DOI 10.1002/jmv.27077, PubMed 33974276 -
Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database
Rheumatology (Oxford), 61 (1), 213-222
DOI 10.1093/rheumatology/keab302, PubMed 33769468 -
Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic review
ERJ Open Res, 7 (1)
DOI 10.1183/23120541.00235-2020, PubMed 33644224 -
Identifying unmet needs in SSc-ILD by semi-qualitative in-depth interviews
Rheumatology (Oxford), 60 (12), 5601-5609
DOI 10.1093/rheumatology/keab154, PubMed 33587103 -
The anti-inflammatory cytokine response characterized by elevated interleukin-10 is a stronger predictor of severe disease and poor outcomes than the pro-inflammatory cytokine response in coronavirus disease 2019 (COVID-19)
Clin Chem Lab Med, 59 (3), 599-607
DOI 10.1515/cclm-2020-1284, PubMed 33554561 -
Association of Lymphangiogenic Factors With Pulmonary Arterial Hypertension in Systemic Sclerosis
Arthritis Rheumatol, 73 (7), 1277-1287
DOI 10.1002/art.41665, PubMed 33497027 -
Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial
Lancet Respir Med, 9 (1), 96-106
DOI 10.1016/S2213-2600(20)30330-1, PubMed 33412120 -
Estimation of the Prevalence of Progressive Fibrosing Interstitial Lung Diseases: Systematic Literature Review and Data from a Physician Survey
Adv Ther, 38 (2), 854-867
DOI 10.1007/s12325-020-01578-6, PubMed 33315170 -
The power of the EUSTAR cohort: key findings to date and implications for management of systemic sclerosis patients
Expert Rev Clin Immunol, 16 (11), 1065-1074
DOI 10.1080/1744666X.2021.1836962, PubMed 33076716 -
Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)
Ann Rheum Dis, 80 (2), 143-150
DOI 10.1136/annrheumdis-2020-217230, PubMed 33037004 -
Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database
Ann Rheum Dis, 80 (2), 219-227
DOI 10.1136/annrheumdis-2020-217455, PubMed 32988845 -
Lymphopenia and neutrophilia at admission predicts severity and mortality in patients with COVID-19: a meta-analysis
Acta Biomed, 91 (3), e2020008
DOI 10.23750/abm.v91i3.10217, PubMed 32921706 -
Detection, screening, and classification of interstitial lung disease in patients with systemic sclerosis
Curr Opin Rheumatol, 32 (6), 497-504
DOI 10.1097/BOR.0000000000000741, PubMed 32890027 -
Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis
Am J Emerg Med, 38 (9), 1722-1726
DOI 10.1016/j.ajem.2020.05.073, PubMed 32738466 -
The need for a holistic approach for SSc-ILD - achievements and ambiguity in a devastating disease
Respir Res, 21 (1), 197
DOI 10.1186/s12931-020-01459-0, PubMed 32703199 -
ILD-specific health-related quality of life in systemic sclerosis-associated ILD compared with IPF
BMJ Open Respir Res, 7 (1)
DOI 10.1136/bmjresp-2020-000598, PubMed 32576559 -
Do sex-specific immunobiological factors and differences in angiotensin converting enzyme 2 (ACE2) expression explain increased severity and mortality of COVID-19 in males?
Diagnosis (Berl), 7 (4), 385-386
DOI 10.1515/dx-2020-0054, PubMed 32549125 -
Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial
PLoS One, 15 (5), e0232739
DOI 10.1371/journal.pone.0232739, PubMed 32437393 -
Tocilizumab in COVID-19: Beware the risk of intestinal perforation
Int J Antimicrob Agents, 56 (1), 106009
DOI 10.1016/j.ijantimicag.2020.106009, PubMed 32389721 -
Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis
Clin Chim Acta, 507, 167-173
DOI 10.1016/j.cca.2020.04.027, PubMed 32348783 -
Prevalence of foramen arcuale and its clinical significance: A meta-analysis of 55,985 subjects: <b>PS095</b>
Porto Biomed J, 2 (5), 190
DOI 10.1016/j.pbj.2017.07.036, PubMed 32258648 -
Clinical Characteristics of Covid-19 in China
N Engl J Med, 382 (19), 1860-1861
DOI 10.1056/NEJMc2005203, PubMed 32220205 -
Multidimensional tracking of phenotypes and organ involvement in a complete nationwide systemic sclerosis cohort
Rheumatology (Oxford), 59 (10), 2920-2929
DOI 10.1093/rheumatology/keaa026, PubMed 32097470 -
Predictors of progression in systemic sclerosis patients with interstitial lung disease
Eur Respir J, 55 (5)
DOI 10.1183/13993003.02026-2019, PubMed 32079645 -
Gastrointestinal tract microbiota modifications in systemic sclerosis
Eur J Rheumatol, 7 (Suppl 3), S228-S236
DOI 10.5152/eurjrheum.2019.19103, PubMed 31922474 -
The potential of fecal microbiota transplantation in systemic sclerosis
Expert Rev Clin Immunol, 16 (2), 117-118
DOI 10.1080/1744666X.2019.1707665, PubMed 31858856 -
Systolic Dysfunction in Systemic Sclerosis: Prevalence and Prognostic Implications
ACR Open Rheumatol, 1 (4), 258-266
DOI 10.1002/acr2.1037, PubMed 31777802 -
Endotype-phenotyping may predict a treatment response in progressive fibrosing interstitial lung disease
EBioMedicine, 50, 379-386
DOI 10.1016/j.ebiom.2019.10.050, PubMed 31732480 -
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
Nat Commun, 10 (1), 4955
DOI 10.1038/s41467-019-12760-y, PubMed 31672989 -
Current and future perspectives on management of systemic sclerosis-associated interstitial lung disease
Expert Rev Clin Immunol, 15 (10), 1009-1017
DOI 10.1080/1744666X.2020.1668269, PubMed 31566449 -
[New ways in the treatment of SSc-ILD: what makes sense?]
Z Rheumatol, 78 (9), 863-864
DOI 10.1007/s00393-019-00704-2, PubMed 31485729 -
Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort
Am J Respir Crit Care Med, 200 (10), 1258-1266
DOI 10.1164/rccm.201903-0486OC, PubMed 31310156 -
Reply
Arthritis Rheumatol, 71 (7), 1204-1206
DOI 10.1002/art.40908, PubMed 31082000 -
[Tubulointerstitial nephritis and uveitis syndrome]
Tidsskr Nor Laegeforen, 139 (8)
DOI 10.4045/tidsskr.18.0840, PubMed 31062556 -
Setting the international standard for longitudinal follow-up of patients with systemic sclerosis: a Delphi-based expert consensus on core clinical features
RMD Open, 5 (1), e000826
DOI 10.1136/rmdopen-2018-000826, PubMed 30997150 -
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study
Ann Rheum Dis, 78 (7), 979-987
DOI 10.1136/annrheumdis-2018-214816, PubMed 30967395 -
Tolerability and safety of long-term rituximab treatment in systemic inflammatory and autoimmune diseases
Rheumatol Int, 39 (6), 1083-1090
DOI 10.1007/s00296-019-04272-1, PubMed 30923955 -
[Purple urine bag syndrome]
Tidsskr Nor Laegeforen, 139 (6)
DOI 10.4045/tidsskr.18.0677, PubMed 30917642 -
Fatigue in Mastocytosis: A Case Series
Clin Ther, 41 (4), 625-632
DOI 10.1016/j.clinthera.2019.01.016, PubMed 30797624 -
Cyclophosphamide for Systemic Sclerosis-related Interstitial Lung Disease: A Comparison of Scleroderma Lung Study I and II
J Rheumatol, 46 (10), 1316-1325
DOI 10.3899/jrheum.180441, PubMed 30770517 -
The prevalence and anatomy of parathyroid glands: a meta-analysis with implications for parathyroid surgery
Langenbecks Arch Surg, 404 (1), 63-70
DOI 10.1007/s00423-019-01751-8, PubMed 30762091 -
[Coronary artery aneurysms]
Tidsskr Nor Laegeforen, 139 (2)
DOI 10.4045/tidsskr.18.0325, PubMed 30698384 -
Reply
Arthritis Rheumatol, 71 (4), 655-656
DOI 10.1002/art.40816, PubMed 30663863 -
Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease
Arthritis Rheumatol, 71 (6), 972-982
DOI 10.1002/art.40815, PubMed 30624031 -
Augmented concentrations of CX3CL1 are associated with interstitial lung disease in systemic sclerosis
PLoS One, 13 (11), e0206545
DOI 10.1371/journal.pone.0206545, PubMed 30457999 -
FokI as a genetic factor of intervertebral disc degeneration: A PRISMA-compliant systematic review of overlapping meta-analyses
J Clin Neurosci, 60, 36-43
DOI 10.1016/j.jocn.2018.09.028, PubMed 30309807 -
Left Ventricular Diastolic Dysfunction Predicts Mortality in Patients With Systemic Sclerosis
J Am Coll Cardiol, 72 (15), 1804-1813
DOI 10.1016/j.jacc.2018.07.068, PubMed 30286924 -
CCL21 as a potential biomarker for pulmonary arterial hypertension in systemic sclerosis
Arthritis Rheumatol (in press)
DOI 10.1002/art.40740, PubMed 30281215 -
Mortality and causes of death across the systemic connective tissue diseases and the primary systemic vasculitides
Rheumatology (Oxford), 58 (2), 313-320
DOI 10.1093/rheumatology/key285, PubMed 30281089 -
Incidence, Risk Factors, and Comorbidities of Vocal Cord Paralysis After Surgical Closure of a Patent Ductus Arteriosus: A Meta-analysis
Pediatr Cardiol, 40 (1), 116-125
DOI 10.1007/s00246-018-1967-8, PubMed 30167748 -
Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model
Ann Rheum Dis, 77 (9), 1326-1332
DOI 10.1136/annrheumdis-2018-213201, PubMed 29875097 -
CCL21 as a Potential Serum Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis
Arthritis Rheumatol, 70 (10), 1644-1653
DOI 10.1002/art.40534, PubMed 29687634 -
Consensus guidelines for the uniform reporting of study ethics in anatomical research within the framework of the anatomical quality assurance (AQUA) checklist
Clin Anat, 31 (4), 521-524
DOI 10.1002/ca.23069, PubMed 29532521 -
[Cardiac sarcoidosis]
Tidsskr Nor Laegeforen, 138 (4)
DOI 10.4045/tidsskr.17.0701, PubMed 29460602 -
Systematic reviews versus narrative reviews in clinical anatomy: Methodological approaches in the era of evidence-based anatomy
Clin Anat, 31 (3), 364-367
DOI 10.1002/ca.23042, PubMed 29322553 -
The prevalence and morphology of the corona mortis (Crown of death): A meta-analysis with implications in abdominal wall and pelvic surgery
Injury, 49 (2), 302-308
DOI 10.1016/j.injury.2017.12.007, PubMed 29241998 -
Frequencies of borderline pulmonary hypertension before and after the DETECT algorithm: results from a prospective systemic sclerosis cohort
Rheumatology (Oxford), 57 (3), 480-487
DOI 10.1093/rheumatology/kex435, PubMed 29237073 -
Cervical Rib Prevalence and its Association with Thoracic Outlet Syndrome: A Meta-Analysis of 141 Studies with Surgical Considerations
World Neurosurg, 110, e965-e978
DOI 10.1016/j.wneu.2017.11.148, PubMed 29203316 -
A travelling camper with a spiking fever, headache, myalgia, hepatitis, and intracellular inclusions
Lancet Infect Dis, 17 (12), 1318
DOI 10.1016/S1473-3099(17)30305-5, PubMed 29173891 -
[A woman in her 60s with diarrhea and joint pain]
Tidsskr Nor Laegeforen, 137 (19)
DOI 10.4045/tidsskr.17.0195, PubMed 29043718 -
IgG4-related disease
Tidsskr Nor Laegeforen, 137 (16)
DOI 10.4045/tidsskr.16.1099, PubMed 28871762 -
Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic Sclerosis
Arthritis Rheumatol, 69 (11), 2209-2221
DOI 10.1002/art.40229, PubMed 28805015 -
Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohorts
BMJ Open Gastroenterol, 4 (1), e000134
DOI 10.1136/bmjgast-2017-000134, PubMed 28761687 -
The prevalence and morphometry of an accessory spleen: A meta-analysis and systematic review of 22,487 patients
Int J Surg, 45, 18-28
DOI 10.1016/j.ijsu.2017.07.045, PubMed 28716661 -
An MIF Promoter Polymorphism Is Associated with Susceptibility to Pulmonary Arterial Hypertension in Diffuse Cutaneous Systemic Sclerosis
J Rheumatol, 44 (10), 1453-1457
DOI 10.3899/jrheum.161369, PubMed 28668810 -
Prevalence of foramen arcuale and its clinical significance: a meta-analysis of 55,985 subjects
J Neurosurg Spine, 27 (3), 276-290
DOI 10.3171/2017.1.SPINE161092, PubMed 28621616 -
[Hypoxia or hypoxemia?]
Tidsskr Nor Laegeforen, 137 (7), 554
DOI 10.4045/tidsskr.16.1146, PubMed 28383233 -
The current state of intermittent intraoperative neural monitoring for prevention of recurrent laryngeal nerve injury during thyroidectomy: a PRISMA-compliant systematic review of overlapping meta-analyses
Langenbecks Arch Surg, 402 (4), 663-673
DOI 10.1007/s00423-017-1580-y, PubMed 28378238 -
Zuckerkandl's tubercle and its relationship to the recurrent laryngeal nerve: A cadaveric dissection and meta-analysis
Auris Nasus Larynx, 44 (6), 639-647
DOI 10.1016/j.anl.2017.03.013, PubMed 28377109 -
Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II
Arthritis Rheumatol, 69 (7), 1451-1460
DOI 10.1002/art.40114, PubMed 28376288 -
The Non-Recurrent Laryngeal Nerve: a meta-analysis and clinical considerations
PeerJ, 5, e3012
DOI 10.7717/peerj.3012, PubMed 28344898 -
The Reliability of the Tracheoesophageal Groove and the Ligament of Berry as Landmarks for Identifying the Recurrent Laryngeal Nerve: A Cadaveric Study and Meta-Analysis
Biomed Res Int, 2017, 4357591
DOI 10.1155/2017/4357591, PubMed 28271065 -
Variations in the Arterial Blood Supply to the Penis and the Accessory Pudendal Artery: A Meta-Analysis and Review of Implications in Radical Prostatectomy
J Urol, 198 (2), 345-353
DOI 10.1016/j.juro.2017.01.080, PubMed 28202357 -
Cardiopulmonary Disease Development in Anti-RNA Polymerase III-positive Systemic Sclerosis: Comparative Analyses from an Unselected, Prospective Patient Cohort
J Rheumatol, 44 (4), 459-465
DOI 10.3899/jrheum.160867, PubMed 28089974 -
The Anastomoses of the Recurrent Laryngeal Nerve in the Larynx: A Meta-Analysis and Systematic Review
J Voice, 31 (4), 495-503
DOI 10.1016/j.jvoice.2016.11.004, PubMed 27939121 -
Development of the Anatomical Quality Assurance (AQUA) checklist: Guidelines for reporting original anatomical studies
Clin Anat, 30 (1), 14-20
DOI 10.1002/ca.22800, PubMed 27801507 -
Development of the anatomical quality assessment (AQUA) tool for the quality assessment of anatomical studies included in meta-analyses and systematic reviews
Clin Anat, 30 (1), 6-13
DOI 10.1002/ca.22799, PubMed 27718281 -
Variable relationship of the recurrent laryngeal nerve to the inferior thyroid artery: A meta-analysis and surgical implications
Head Neck, 39 (1), 177-186
DOI 10.1002/hed.24582, PubMed 27627737 -
Interstitial lung disease in systemic sclerosis: progress in screening and early diagnosis
Curr Opin Rheumatol, 28 (6), 613-8
DOI 10.1097/BOR.0000000000000323, PubMed 27387267 -
A man in his 30s with ulcerative colitis and pancytopenia
Tidsskr Nor Laegeforen, 136 (11), 1010-4
DOI 10.4045/tidsskr.15.0958, PubMed 27325035 -
OX40L blockade protects against inflammation-driven fibrosis
Proc Natl Acad Sci U S A, 113 (27), E3901-10
DOI 10.1073/pnas.1523512113, PubMed 27298374 -
Extralaryngeal branching of the recurrent laryngeal nerve: a meta-analysis of 28,387 nerves
Langenbecks Arch Surg, 401 (7), 913-923
DOI 10.1007/s00423-016-1455-7, PubMed 27251487 -
Prevalence of the accessory deep peroneal nerve: A cadaveric study and meta-analysis
Clin Neurol Neurosurg, 144, 105-11
DOI 10.1016/j.clineuro.2016.03.026, PubMed 27038872 -
High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis
Chest, 150 (2), 299-306
DOI 10.1016/j.chest.2016.03.004, PubMed 26997242 -
The origin of the medial circumflex femoral artery: a meta-analysis and proposal of a new classification system
PeerJ, 4, e1726
DOI 10.7717/peerj.1726, PubMed 26966661 -
Correction: Anatomical Variations in the Sinoatrial Nodal Artery: A Meta-Analysis and Clinical Considerations
PLoS One, 11 (3), e0150051
DOI 10.1371/journal.pone.0150051, PubMed 26930468 -
Surgical anatomy of the sciatic nerve: A meta-analysis
J Orthop Res, 34 (10), 1820-1827
DOI 10.1002/jor.23186, PubMed 26856540 -
Anatomical Variations in the Sinoatrial Nodal Artery: A Meta-Analysis and Clinical Considerations
PLoS One, 11 (2), e0148331
DOI 10.1371/journal.pone.0148331, PubMed 26849441 -
Variations in the origin of the deep femoral artery: A meta-analysis
Clin Anat, 30 (1), 106-113
DOI 10.1002/ca.22691, PubMed 26780216 -
Dr. Hoffmann-Vold replies
J Rheumatol, 42 (12), 2513
DOI 10.3899/jrheum.150886, PubMed 26628710 -
Median and ulnar nerve anastomoses in the upper limb: A meta-analysis
Muscle Nerve, 54 (1), 36-47
DOI 10.1002/mus.24993, PubMed 26599506 -
The prevalence and anatomical characteristics of the accessory head of the flexor pollicis longus muscle: a meta-analysis
PeerJ, 3, e1255
DOI 10.7717/peerj.1255, PubMed 26557419 -
Procalcitonin as a Serum Biomarker for Differentiation of Bacterial Meningitis From Viral Meningitis in Children: Evidence From a Meta-Analysis
Clin Pediatr (Phila), 55 (8), 749-64
DOI 10.1177/0009922815606414, PubMed 26378091 -
Anatomical variations of the formation and course of the sural nerve: A systematic review and meta-analysis
Ann Anat, 202, 36-44
DOI 10.1016/j.aanat.2015.08.002, PubMed 26342158 -
Associations between circulating endostatin levels and vascular organ damage in systemic sclerosis and mixed connective tissue disease: an observational study
Arthritis Res Ther, 17 (1), 231
DOI 10.1186/s13075-015-0756-5, PubMed 26315510 -
The Prevalence of Anatomical Variations of the Median Nerve in the Carpal Tunnel: A Systematic Review and Meta-Analysis
PLoS One, 10 (8), e0136477
DOI 10.1371/journal.pone.0136477, PubMed 26305098 -
Association of migraine headaches with anatomical variations of the Circle of Willis: Evidence from a meta-analysis
Neurol Neurochir Pol, 49 (4), 272-7
DOI 10.1016/j.pjnns.2015.06.002, PubMed 26188945 -
The role of serum procalcitonin in the diagnosis of bacterial meningitis in adults: a systematic review and meta-analysis
Int J Infect Dis, 38, 68-76
DOI 10.1016/j.ijid.2015.07.011, PubMed 26188130 -
Predictive value of serial high-resolution computed tomography analyses and concurrent lung function tests in systemic sclerosis
Arthritis Rheumatol, 67 (8), 2205-12
DOI 10.1002/art.39166, PubMed 25916462 -
Performance of the 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis (SSc) in large, well-defined cohorts of SSc and mixed connective tissue disease
J Rheumatol, 42 (1), 60-3
DOI 10.3899/jrheum.140047, PubMed 25274890 -
Dysfunctional arteriovenous anastomoses in hands of systemic sclerosis patients with digital ulcers
Clin Exp Rheumatol, 32 (6 Suppl 86), S-53-9
PubMed 24847906 -
Survival and causes of death in an unselected and complete cohort of Norwegian patients with systemic sclerosis
J Rheumatol, 40 (7), 1127-33
DOI 10.3899/jrheum.121390, PubMed 23637316 -
Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility
Ann Rheum Dis, 72 (7), 1233-8
DOI 10.1136/annrheumdis-2012-202357, PubMed 23172754 -
Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study
Ann Rheum Dis, 72 (4), 602-7
DOI 10.1136/annrheumdis-2012-201888, PubMed 22896740 -
Prevalence of systemic sclerosis in south-east Norway
Rheumatology (Oxford), 51 (9), 1600-5
DOI 10.1093/rheumatology/kes076, PubMed 22539477 -
A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosis
Arthritis Res Ther, 14 (2), R85
DOI 10.1186/ar3809, PubMed 22531499 -
Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population
Rheumatology (Oxford), 50 (11), 1976-81
DOI 10.1093/rheumatology/ker259, PubMed 21875883 -
Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy
PLoS Genet, 7 (7), e1002178
DOI 10.1371/journal.pgen.1002178, PubMed 21779181 -
Association of a non-synonymous functional variant of the ITGAM gene with systemic sclerosis
Ann Rheum Dis, 70 (11), 2050-2
DOI 10.1136/ard.2010.148874, PubMed 21571730 -
Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus
Nat Genet, 42 (5), 426-9
DOI 10.1038/ng.565, PubMed 20383147 -
Long-term outcome and prognostic factors in enthesitis-related arthritis: a case-control study
Arthritis Rheum, 54 (11), 3573-82
DOI 10.1002/art.22181, PubMed 17075863 -
IgG4-related disease
Tidsskr. Nor. Laegeforen., 137 (16), 1201-1204 -
Tubulointerstitial nephritis and uveitis syndrome
Tidsskr. Nor. Laegeforen., 139 (8), 736-738 -
A 60-year-old woman with diarrhea and joint pain
Tidsskr. Nor. Laegeforen., 137 (19), 1524-1528 -
New ways in the treatment of SSc-ILD: what makes sense?
Pneumologe, 16 (5), 303-304
DOI 10.1007/s10405-019-0269-z -
Aneurysms in coronary arteries
Tidsskr. Nor. Laegeforen., 139 (2), 174-175 -
Purple urine bag syndrome
Tidsskr. Nor. Laegeforen., 139 (6), 543-544